
Jeremy Veenstra-VanderWeele
Co-Director, NIMH T32 Postdoctoral Fellowship for Translational Research in Child Psychiatric Disorders · Columbia University Irving Medical Center
Credentials: · · · · ·
History
- Present
NIMH T32 Postdoctoral Fellowship for Translational Research in Child Psychiatric Disorders Fellowship · Columbia University Irving Medical Center
- Present
Child & Adolescent Psychiatry · Columbia University Irving Medical Center
PresentDepartment of Psychiatry · Columbia University, Vagelos College of Physicians and Surgeons
2027–2028- 2004–2006
University of Chicago Hospitals
Research
Review · The Lancet · 2018 · Last of 4 authors · 1,584 citations
A systematic review of early intensive intervention for autism spectrum disorders
Systematic review or meta-analysis · PEDIATRICS · 2011 · Last of 6 authors · 412 citations
The serotonin system in autism spectrum disorder: From biomarker to animal models
Review · Neuroscience · 2016 · Last of 3 authors · Corresponding · 398 citations

35 papers

15 papers
- KS
15 papers

14 papers · 1 as a fellow
- EA
14 papers
- BL
13 papers

11 papers

11 papers · 4 as a resident
Grants
- 1980–2031
Translational Research Training in Child Psychiatry
National Institute of Mental Health · T32
Contact PI · $3.9M · Columbia University Health Sciences
- 2021–2031
Research Education in Child and Adolescent Psychiatry Residency
National Institute of Mental Health · R25
Contact PI · $1.3M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
- 2026–2028
Gestational Serotonin Levels and Offspring Neurodevelopment
National Institute of Mental Health · R21
Contact PI · $467.4K · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
- 2022–2027
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
National Institute of Child Health and Human Development · P50
Contact PI · $11.7M · Columbia University Health Sciences
Clinical trials
- 2026–2028
Principal investigator · Recruiting · Phase 2
Jeremy Veenstra-vanderweele
- 2025–2027
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Principal investigator · Recruiting · Phase 2
New York State Psychiatric Institute
- 2009
Biomarker and DNA Collection in Subjects Participating in Protocol 22003
Principal investigator · Completed
Seaside Therapeutics, Inc.
- 2009–2010
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
Principal investigator · Completed · Phase 2
Seaside Therapeutics, Inc.



